Ironwood Pharmaceuticals, Inc. IRWD

4.13 (0.06) (1.43%) as of 25 Sep
Market cap
$692.4M
P/E
5.2×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
389.32 361.51 296.15 338.99

+8 more TTM periods

Gross Profit
389.32 361.51 296.15 338.99
Operating Income
234.17 200.18 98.50 123.19
EBT
207.38 171.47 70.03 93.57
Income after Tax
129.87 102.18 24.02 28.55
Net Income Common
129.87 102.18 24.02 28.55
Gross Margin
100.00% 100.00% 100.00% 100.00%
EBIT Margin
60.15% 55.37% 33.26% 36.34%
Net Profit Margin
33.36% 28.26% 8.11% 8.42%
Free Cash Flow Margin
47.66% 31.04% 42.89% 19.96%
EBITDA
236.00 202.03 100.38 125.09
EBIT
234.17 200.18 98.50 123.19

Show all line items

In millions of $ except per-share values · columns are period end dates